Daily as of 3 Nov 16:00 ET
- Price
- below both $3.74 vs 50 $3.76 / 200 $5.80
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 8 Apr 2026 · projected 29 bars out · tested 1 bar
FULC | Fulcrum TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$3.74
+$0.09 (+2.47%)
Fulcrum Therapeutics (FULC) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2020.
The 50 SMA has sat below the 200 on the daily since Apr 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the weekly, price sits below the 50 and the 200; on the 4-hour it is above both. On the weekly a death cross is projected within 10 bars.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- below both $3.71 vs 50 $6.75 / 200 $6.18
- Projection
- 💀Death cross projected in 9 bars
- Test
- No active test
- Last cross
- 🟨Golden cross week of 29 Dec 2025 · projected 26 bars out
4-hour as of 3 Nov 16:00 ET
- Price
- above both $3.74 vs 50 $3.70 / 200 $3.73
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 27 Oct 2026 bar 1 · projected 2 bars out · tested 4 bars
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 27 Oct 2026 | 💀Death | 4-hour | 2 bars out | 4 bar cross test |
| 22 Oct 2026 | 🟨Golden | 4-hour | 6 bars out | 1 bar cross test |
| 8 Apr 2026 | 💀Death steep | daily | 29 bars out | 1 bar cross test |
| 2 Mar 2026 | 💀Death | 4-hour | 12 bars out | Not tested |
| week of 29 Dec 2025 | 🟨Golden moderate | weekly | 26 bars out | Not tested |
About FULC
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$5M
4-hour coverageYes, since Oct 2025
History on recordSince 2020
SectorHealthcare
Cap bandmicro